Osteoporosis Update

Proceedings of the 2013 Santa Fe Bone Symposium

E. Michael Lewiecki, John P. Bilezikian, Lynda Bonewald, Juliet E. Compston, Robert P. Heaney, Douglas P. Kiel, Paul D. Miller, John T. Schousboe

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

The 2013 Santa Fe Bone Symposium included plenary sessions on new developments in the fields of osteoporosis and metabolic bone disease, oral presentations of abstracts, and faculty panel discussions of common clinical conundrums: scenarios of perplexing circumstances where treatment decisions are not clearly defined by current medical evidence and clinical practice guidelines. Controversial issues in the care of osteoporosis were reviewed and discussed by faculty and participants. This is a review of the proceedings of the Santa Fe Bone Symposium, constituting in its entirety an update of advances in the understanding of selected bone disease topics of interest and the implications for managing patients in clinical practice. Topics included the associations of diabetes and obesity with skeletal fragility, the complexities and pitfalls in assessing the benefits and potential adverse effects of nutrients for treatment of osteoporosis, uses of dual-energy X-ray absorptiometry beyond measurement of bone mineral density, challenges in the care of osteoporosis in the very elderly, new findings on the role of osteocytes in regulating bone remodeling, and current concepts on the use of bone turnover markers in managing patients with chronic kidney disease who are at high risk for fracture.

Original languageEnglish (US)
Pages (from-to)330-343
Number of pages14
JournalJournal of Clinical Densitometry
Volume17
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Osteoporosis
Bone and Bones
Bone Remodeling
Osteocytes
Metabolic Bone Diseases
Bone Diseases
Photon Absorptiometry
Chronic Renal Insufficiency
Practice Guidelines
Bone Density
Obesity
Food
Therapeutics

Keywords

  • Controversy
  • Emerging
  • Osteoporosis
  • Safety
  • Treatment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Lewiecki, E. M., Bilezikian, J. P., Bonewald, L., Compston, J. E., Heaney, R. P., Kiel, D. P., ... Schousboe, J. T. (2014). Osteoporosis Update: Proceedings of the 2013 Santa Fe Bone Symposium. Journal of Clinical Densitometry, 17(3), 330-343. https://doi.org/10.1016/j.jocd.2013.11.006

Osteoporosis Update : Proceedings of the 2013 Santa Fe Bone Symposium. / Lewiecki, E. Michael; Bilezikian, John P.; Bonewald, Lynda; Compston, Juliet E.; Heaney, Robert P.; Kiel, Douglas P.; Miller, Paul D.; Schousboe, John T.

In: Journal of Clinical Densitometry, Vol. 17, No. 3, 2014, p. 330-343.

Research output: Contribution to journalReview article

Lewiecki, EM, Bilezikian, JP, Bonewald, L, Compston, JE, Heaney, RP, Kiel, DP, Miller, PD & Schousboe, JT 2014, 'Osteoporosis Update: Proceedings of the 2013 Santa Fe Bone Symposium', Journal of Clinical Densitometry, vol. 17, no. 3, pp. 330-343. https://doi.org/10.1016/j.jocd.2013.11.006
Lewiecki, E. Michael ; Bilezikian, John P. ; Bonewald, Lynda ; Compston, Juliet E. ; Heaney, Robert P. ; Kiel, Douglas P. ; Miller, Paul D. ; Schousboe, John T. / Osteoporosis Update : Proceedings of the 2013 Santa Fe Bone Symposium. In: Journal of Clinical Densitometry. 2014 ; Vol. 17, No. 3. pp. 330-343.
@article{df38366b063041c583895c39a16ce2b1,
title = "Osteoporosis Update: Proceedings of the 2013 Santa Fe Bone Symposium",
abstract = "The 2013 Santa Fe Bone Symposium included plenary sessions on new developments in the fields of osteoporosis and metabolic bone disease, oral presentations of abstracts, and faculty panel discussions of common clinical conundrums: scenarios of perplexing circumstances where treatment decisions are not clearly defined by current medical evidence and clinical practice guidelines. Controversial issues in the care of osteoporosis were reviewed and discussed by faculty and participants. This is a review of the proceedings of the Santa Fe Bone Symposium, constituting in its entirety an update of advances in the understanding of selected bone disease topics of interest and the implications for managing patients in clinical practice. Topics included the associations of diabetes and obesity with skeletal fragility, the complexities and pitfalls in assessing the benefits and potential adverse effects of nutrients for treatment of osteoporosis, uses of dual-energy X-ray absorptiometry beyond measurement of bone mineral density, challenges in the care of osteoporosis in the very elderly, new findings on the role of osteocytes in regulating bone remodeling, and current concepts on the use of bone turnover markers in managing patients with chronic kidney disease who are at high risk for fracture.",
keywords = "Controversy, Emerging, Osteoporosis, Safety, Treatment",
author = "Lewiecki, {E. Michael} and Bilezikian, {John P.} and Lynda Bonewald and Compston, {Juliet E.} and Heaney, {Robert P.} and Kiel, {Douglas P.} and Miller, {Paul D.} and Schousboe, {John T.}",
year = "2014",
doi = "10.1016/j.jocd.2013.11.006",
language = "English (US)",
volume = "17",
pages = "330--343",
journal = "Journal of Clinical Densitometry",
issn = "1094-6950",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Osteoporosis Update

T2 - Proceedings of the 2013 Santa Fe Bone Symposium

AU - Lewiecki, E. Michael

AU - Bilezikian, John P.

AU - Bonewald, Lynda

AU - Compston, Juliet E.

AU - Heaney, Robert P.

AU - Kiel, Douglas P.

AU - Miller, Paul D.

AU - Schousboe, John T.

PY - 2014

Y1 - 2014

N2 - The 2013 Santa Fe Bone Symposium included plenary sessions on new developments in the fields of osteoporosis and metabolic bone disease, oral presentations of abstracts, and faculty panel discussions of common clinical conundrums: scenarios of perplexing circumstances where treatment decisions are not clearly defined by current medical evidence and clinical practice guidelines. Controversial issues in the care of osteoporosis were reviewed and discussed by faculty and participants. This is a review of the proceedings of the Santa Fe Bone Symposium, constituting in its entirety an update of advances in the understanding of selected bone disease topics of interest and the implications for managing patients in clinical practice. Topics included the associations of diabetes and obesity with skeletal fragility, the complexities and pitfalls in assessing the benefits and potential adverse effects of nutrients for treatment of osteoporosis, uses of dual-energy X-ray absorptiometry beyond measurement of bone mineral density, challenges in the care of osteoporosis in the very elderly, new findings on the role of osteocytes in regulating bone remodeling, and current concepts on the use of bone turnover markers in managing patients with chronic kidney disease who are at high risk for fracture.

AB - The 2013 Santa Fe Bone Symposium included plenary sessions on new developments in the fields of osteoporosis and metabolic bone disease, oral presentations of abstracts, and faculty panel discussions of common clinical conundrums: scenarios of perplexing circumstances where treatment decisions are not clearly defined by current medical evidence and clinical practice guidelines. Controversial issues in the care of osteoporosis were reviewed and discussed by faculty and participants. This is a review of the proceedings of the Santa Fe Bone Symposium, constituting in its entirety an update of advances in the understanding of selected bone disease topics of interest and the implications for managing patients in clinical practice. Topics included the associations of diabetes and obesity with skeletal fragility, the complexities and pitfalls in assessing the benefits and potential adverse effects of nutrients for treatment of osteoporosis, uses of dual-energy X-ray absorptiometry beyond measurement of bone mineral density, challenges in the care of osteoporosis in the very elderly, new findings on the role of osteocytes in regulating bone remodeling, and current concepts on the use of bone turnover markers in managing patients with chronic kidney disease who are at high risk for fracture.

KW - Controversy

KW - Emerging

KW - Osteoporosis

KW - Safety

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84905026246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905026246&partnerID=8YFLogxK

U2 - 10.1016/j.jocd.2013.11.006

DO - 10.1016/j.jocd.2013.11.006

M3 - Review article

VL - 17

SP - 330

EP - 343

JO - Journal of Clinical Densitometry

JF - Journal of Clinical Densitometry

SN - 1094-6950

IS - 3

ER -